Lancet
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.Kimathi D
Juan-Giner A
Bob NS
Orindi B
Namulwana ML
Diatta A
Cheruiyot S
Fall G
Dia M
Hamaluba MM
Nyehangane D
Karanja HK
Gitonga JN
Mugo D
Omuoyo DO
Hussein M
Oloo E
Kamau N
Wafula J
Bendera J
Silvester N
Mwavita J
Joshua M
Thuranira JM
Agababyona C
Ngetsa C
Aisha N
Moki F
Buluku T
Munene M
Mwanga-Amumpaire J
Lutwama J
Kayiwa J
Kamaara E
Barrett AD
Kaleebu P
Bejon P
Sall AA
Grais RF
Warimwe GM
Lancet, (2026). 407:497-504
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.GBDDemographics Collaborators
Lancet, (2025). 406:1731-1810
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.GBDDisease
Injury,
Risk Factor Collaborators
Lancet, (2025). 406:1873-1922
Integrating gender and equity commitments in the revised global action plan on antimicrobial resistance.Batheja D
Saint V
Dobreva Z
Goel S
Lewycka S
Mutua E
Nayiga S
Paulin-Deschenaux S
Simpson SJ
Steege R
Westwood E
Charani E
Mpundu M
Balachandran A
Lancet, (2025). 406:1200-1203
A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.Singh B
Lipunga GD
Thangavelu P
Dhar S
Ferreira Cronemberger L
Abhilash KPP
Abraham AM
de Brito CAA
Brito Ferreira ML
Chandrashekar N
Duarte R
Fajardo Modol A
Ghale BC
Kang G
Gowda VK
Kuriakose K
Lant S
Mallewa M
Mbale E
Moore SC
Mwangalika G
Kamath PBT
Navvuga P
Nyondo-Mipando AL
Phiri TJ
Pimentel Lopes de Melo C
Pradeep BS
Rawlinson R
Sheha I
Thomas PT
Newton CR
de Sequeira PC
Sejvar JJ
Dua T
Turtle L
Verghese VP
Arraes Lwms
Desmond N
Easton A
Jones JA
Lilford RJ
Netravathi M
McGill F
Michael BD
Mwapasa V
Griffiths MJ
Parry CM
Ravi V
Burnside G
Brain Infections Global Intervention Study Group
Cornick J
Franca RFO
Desai AS
Rupali P
Solomon T
Lancet, (2025). 405:991-1003
Regional action needed to halt antimalarial drug resistance in Africa.Martinez-Vega R
Ishengoma DS
Gosling R
Rosenthal PJ
Dondorp A
Barnes KI
Nsanzabana C
Djimde AA
Ochola-Oyier LI
Tibenderana J
Chimumbwa J
Golassa L
Kapologwe NA
Mbacham WF
Kamya MR
Fidock DA
Komatsu R
von Seidlein L
Dhorda M
Lancet, (2025). 405:7-10
Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact.Berkley JA
Walson JL
Bahl R
Rollins N
Lancet, (2024). 404:492-494
Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.Asante KP
Mathanga DP
Milligan P
Akech S
Oduro A
Mwapasa V
Moore KA
Kwambai TK
Hamel MJ
Gyan T
Westercamp N
Kapito-Tembo A
Njuguna P
Ansong D
Kariuki S
Mvalo T
Snell P
Schellenberg D
Welega P
Otieno L
Chimala A
Afari EA
Bejon P
Maleta K
Agbenyega T
Snow RW
Zulu M
Chinkhumba J
Samuels AM
Malaria Vaccine Programme Evaluation Partners
Lancet, (2024). 403:1660-1670
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.GBDDemographics Collaborators
Lancet, (2024). 403:1989-2056
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.Datoo MS
Dicko A
Tinto H
Ouedraogo JB
Hamaluba M
Olotu A
Beaumont E
Ramos Lopez F
Natama HM
Weston S
Chemba M
Compaore YD
Issiaka D
Salou D
Some AM
Omenda S
Lawrie A
Bejon P
Rao H
Chandramohan D
Roberts R
Bharati S
Stockdale L
Gairola S
Greenwood BM
Ewer KJ
Bradley J
Kulkarni PS
Shaligram U
Hill AVS
R1/Matrix-M Phase 3 Trial Group
Lancet, (2024). 403:533-544
How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging
Pandemic Infectious DiseasesElectronic address mark jit lshtm ac uk
Lancet, (2024). 403:789-791
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.Public Health Collaborators on Serosurveillance for Pandemic Preparedness
Response PHSeroPPR
Lancet, (2023). 402:356-358
Intersectional insights into racism and health: not just a question of identity.Shannon G
Morgan R
Zeinali Z
Brady L
Couto MT
Devakumar D
Eder B
Karadag O
Mukherjee M
Peres MFT
Ryngelblum M
Sabharwal N
Schonfield A
Silwane P
Singh D
Van Ryneveld M
Vilakati S
Watego C
Whyle E
Muraya K
Lancet, (2022). 400:2125-2136
Executive summary.Devakumar D
Abubakar I
Tendayi Achiume E
Muraya K
Paradies Y
Saini A
Selvarajah S
Shannon G
Lancet, (2022). 400:2095-2096
Substantial misdiagnosis of severe malaria in African children.White NJ
Watson JA
Uyoga S
Williams TN
Maitland KM
Lancet, (2022). 400:807
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.Li Y
Wang X
Blau DM
Caballero MT
Feikin DR
Gill CJ
Madhi SA
Omer SB
Simoes EAF
Campbell H
Pariente AB
Bardach D
Bassat Q
Casalegno JS
Chakhunashvili G
Crawford N
Danilenko D
Do LAH
Echavarria M
Gentile A
Gordon A
Heikkinen T
Huang QS
Jullien S
Krishnan A
Lopez EL
Markic J
Mira-Iglesias A
Moore HC
Moyes J
Mwananyanda L
Nokes DJ
Noordeen F
Obodai E
Palani N
Romero C
Salimi V
Satav A
Seo E
Shchomak Z
Singleton R
Stolyarov K
Stoszek SK
von Gottberg A
Wurzel D
Yoshida LM
Yung CF
Zar HJ
Respiratory Virus Global Epidemiology Network
Nair H
Resceu investigators
Lancet, (2022). 399:2047-2064
The Lancet Nigeria Commission: investing in health and the future of the nation.Abubakar I
Dalglish SL
Angell B
Sanuade O
Abimbola S
Adamu AL
Adetifa IMO
Colbourn T
Ogunlesi AO
Onwujekwe O
Owoaje ET
Okeke IN
Adeyemo A
Aliyu G
Aliyu MH
Aliyu SH
Ameh EA
Archibong B
Ezeh A
Gadanya MA
Ihekweazu C
Ihekweazu V
Iliyasu Z
Kwaku Chiroma A
Mabayoje DA
Nasir Sambo M
Obaro S
Yinka-Ogunleye A
Okonofua F
Oni T
Onyimadu O
Pate MA
Salako BL
Shuaib F
Tsiga-Ahmed F
Zanna FH
Lancet, (2022). 399:1155-1200
Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.Angell B
Sanuade O
Adetifa IMO
Okeke IN
Adamu AL
Aliyu MH
Ameh EA
Kyari F
Gadanya MA
Mabayoje DA
Yinka-Ogunleye A
Oni T
Jalo RI
Tsiga-Ahmed FI
Dalglish SL
Abimbola S
Colbourn T
Onwujekwe O
Owoaje ET
Aliyu G
Aliyu SH
Archibong B
Ezeh A
Ihekweazu C
Iliyasu Z
Obaro S
Obadare EB
Okonofua F
Pate M
Salako BL
Zanna FH
Glenn S
Walker A
Ezalarab M
Naghavi M
Abubakar I
Lancet, (2022). 399:1117-1129
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Antimicrobial Resistance Collaborators
Lancet, (2022). 399:629-655
Optimising epilepsy care throughout the Afghan refugee crisis.Sen A
Hallab A
Cross JH
Sander JW
Newton CR
Lancet, (2021). 398:1563
